Replies to post #30900 on Relief Therapeutics Holding AG (RLFTF)

[mchammertime]

Sorry here's the link if you haven't read yet

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-combination-treatment-covid-19

[urgonnatrip]

Been around a lot of rockstar scientists and haven't found many that know s#$t about how to build a brand, develop and launch marketing plans and ultimately understand what it takes to make sure a drug is in every clinic. This is starting to look like a group of self-important fools that will soon be parted from their treasure, potentially without a dime to show for it. Until someone from outside their circle, someone unrelated to the FDA or Neuro or RLF reports on this drug over real media, these guys have failed. It doesn't have to be that way. Instead of some high-powered CFO, spend some bucks on a top-notch PR/marketing firm and ratchet up the buzz. Where's the pressure? Where's the push?

Reminds me of...

"These are the Glengarry leads, and to you, they are gold...and you...don't get them, because giving them to you is just...throwing them away. They're for closers."

[BSfreeMD]

So I don’t think the FDA has completely lost their minds. I agree that we should have an EUA by know, especially given the safety of Aviptadil. The problem is a study with only 165 patients is tiny and has very little power. The initial studies way back on VIP for ARDS looked good until it was in a placebo controlled trial, then it didn’t pan out. I agree it’s nuts there has not been an EAU yet but understand why sorta. The FDA has been burned on other EUA and don’t want to look completely incompetent.